nach oben

International Journal of Colorectal Disease

Erschienen in:

09.07.2019 | Original Article

Role of pre-existing type 2 diabetes in colorectal cancer survival among older Americans: a SEER-Medicare population-based study 2002–2011

verfasst von: Sanae El brahimi, Matthew Lee Smith, Paulo S. Pinheiro

Erschienen in: International Journal of Colorectal Disease | Ausgabe 8/2019

Einloggen, um Zugang zu erhalten

Abstract

Purpose

Type 2 diabetes mellitus (diabetes) is a common comorbid condition among older adult colorectal cancer (CRC) patients, yet its effects on CRC mortality have not been adequately examined. This study aims to investigate the association between pre-existing diabetes, with and without complications, and CRC mortality.

Methods

Medicare beneficiaries 67 years and older diagnosed with CRC between 2002 and 2011 were studied using the Surveillance, Epidemiology, and End Results (SEER)-Medicare datasets. Pre-existing diabetes was ascertained using validated algorithms. Cox proportional hazards models were used to compare all-cause and CRC-cause-specific death risk differences in relation to prior diabetes diagnosis and diabetes severity (with and without complications) with adjustment for relevant patient demographics and disease characteristics.

Results

Analyses included 93,710 CRC patients. Among the study population, 22,155 (24%) had diabetes prior to CRC diagnosis and 4% had diabetes-related complications (neuropathy, nephropathy, retinopathy, or peripheral circulatory disorders). All-cause CRC mortality was significantly higher among diabetic patients compared with non-diabetic patients (hazard ratio (HR) = 1.20; 95% confidence interval (CI) = 1.17–1.23). The results were more pronounced for diabetes with complications (HR = 1.47; 95% CI = 1.34–1.54). Diabetic patients with complications were 16% more likely to die of colorectal cancer compared with patients without diabetes (HR = 1.16; 95% CI = 1.08–1.25).

Conclusion

Pre-existing diabetes contributes to poorer all-cause mortality among CRC patients and increased mortality from CRC among those with diabetes and complications. Opportunities exist to incorporate diabetes prevention and management interventions during CRC treatment phases among older adults.

Boyle JP, Thompson TJ, Gregg EW, Barker LE, Williamson DF (2010) Projection of the year 2050 burden of diabetes in the US adult population: dynamic modeling of incidence, mortality, and prediabetes prevalence. Popul Health Metrics 8(1):29. https://doi.org/10.1186/1478-7954-8-29 CrossRef

Siegel RL, Miller KD, Jemal A (2017) Cancer statistics, 2017. CA Cancer J Clin 67(1):7–30. https://doi.org/10.3322/caac.21395 CrossRefPubMed

Calonge N, Petitti DB, DeWitt TG, Dietrich AJ, Gregory KD, Harris R et al (2008) Screening for colorectal cancer: US Preventive Services Task Force recommendation statement. Ann Intern Med 149(9):627–637. https://doi.org/10.7326/0003-4819-149-9-200811040-00243 CrossRef

Tuomilehto J, Lindström J, Eriksson JG, Valle TT, Hämäläinen H, Ilanne-Parikka P, Keinänen-Kiukaanniemi S, Laakso M, Louheranta A, Rastas M, Salminen V, Aunola S, Cepaitis Z, Moltchanov V, Hakumäki M, Mannelin M, Martikkala V, Sundvall J, Uusitupa M (2001) Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med 344(18):1343–1350. https://doi.org/10.1056/NEJM200105033441801 CrossRefPubMed

Harriss DJ, Atkinson G, Batterham A, George K, Tim Cable N, Reilly T, Haboubi N, Renehan AG, The Colorectal Cancer, Lifestyle, Exercise And Research Group (2009) Lifestyle factors and colorectal cancer risk (2): a systematic review and meta-analysis of associations with leisure-time physical activity. Color Dis 11(7):689–701. https://doi.org/10.1111/j.1463-1318.2009.01767.x CrossRef

Reis JP, Loria CM, Sorlie PD, Park Y, Hollenbeck A, Schatzkin A (2011) Lifestyle factors and risk for new-onset diabetes: a population-based cohort study. Ann Intern Med 155(5):292–299. https://doi.org/10.7326/0003-4819-155-5-201109060-00006 CrossRefPubMedPubMedCentral

Kirkman MS, Briscoe VJ, Clark N, Florez H, Haas LB, Halter JB, Huang ES, Korytkowski MT, Munshi MN, Odegard PS, Pratley RE, Swift CS (2012) Diabetes in older adults. Diabetes Care 35(12):2650–2664. https://doi.org/10.2337/dc12-1801 CrossRefPubMedPubMedCentral

Campbell PT, Deka A, Jacobs EJ, Newton CC, Hildebrand JS, McCullough ML et al (2010) Prospective study reveals associations between colorectal cancer and type 2 diabetes mellitus or insulin use in men. Gastroenterology 139(4):1138–1146. https://doi.org/10.1053/j.gastro.2010.06.072 CrossRefPubMed

Deng L, Gui Z, Zhao L, Wang J, Shen L (2012) Diabetes mellitus and the incidence of colorectal cancer: an updated systematic review and meta-analysis. Dig Dis Sci 57(6):1576–1585. https://doi.org/10.1007/s10620-012-2055-1 CrossRefPubMed

10.

Coughlin SS, Calle EE, Teras LR, Petrelli J, Thun MJ (2004) Diabetes mellitus as a predictor of cancer mortality in a large cohort of US adults. Am J Epidemiol 159(12):1160–1167. https://doi.org/10.1093/aje/kwh161 CrossRefPubMed

11.

Chiao EY, Nambi PV, Naik AD (2010) The impact of diabetes process and outcome quality measures on overall survival in patients with co-morbid colorectal cancer. J Cancer Surviv 4(4):381–387. https://doi.org/10.1007/s11764-010-0141-y CrossRefPubMedPubMedCentral

12.

Warren JL, Klabunde CN, Schrag D, Bach PB, Riley GF (2002) Overview of the SEER-Medicare data: content, research applications, and generalizability to the United States elderly population. Med Care 40(8):18 https://www.jstor.org/stable/3767919. Accessed 1 Jan 2019

13.

Research Data (1973–2010) National Cancer Institute, DCCPS, Surveillance Research Program, Surveillance Systems Branch, released April 2013, based on the November 2012 submission. [Internet].; 2013 [cited July 2013]. Available from: www.seer.cancer.gov

14.

SEER-Medicare: how the SEER and Medicare data are linked [Internet].; 2018 [cited January 1, 2019]. Available from: https://healthcaredelivery.cancer.gov/seermedicare/overview/linked.html. Accessed 1 Jan 2019

15.

Yang Y, Mauldin PD, Ebeling M, Hulsey TC, Liu B, Thomas MB, Camp ER, Esnaola NF (2013) Effect of metabolic syndrome and its components on recurrence and survival in colon cancer patients. Cancer 119(8):1512–1520. https://doi.org/10.1002/cncr.27923 CrossRefPubMed

16.

Hebert PL, Geiss LS, Tierney EF, Engelgau MM, Yawn BP, McBean AM (1999) Identifying persons with diabetes using Medicare claims data. Am J Med Qual 14(6):270–277. https://doi.org/10.1177/106286069901400607 CrossRefPubMed

17.

Coker AL, Du XL, Fang S, Eggleston KS (2006) Socioeconomic status and cervical cancer survival among older women: findings from the SEER–Medicare linked data cohorts. Gynecol Oncol 102(2):278–284. https://doi.org/10.1016/j.ygyno.2005.12.016 CrossRefPubMed

18.

Klabunde CN, Legler JM, Warren JL, Baldwin L, Schrag D (2007) A refined comorbidity measurement algorithm for claims-based studies of breast, prostate, colorectal, and lung cancer patients. Ann Epidemiol 17(8):584–590. https://doi.org/10.1016/j.annepidem.2007.03.011 CrossRefPubMed

19.

Hess KR (1995) Graphical methods for assessing violations of the proportional hazards assumption in Cox regression. Stat Med 14(15):1707–1723CrossRefPubMed

20.

van de Poll-Franse, Lonneke V, Houterman S, Janssen-Heijnen ML, Dercksen MW, Coebergh JWW, Haak HR (2007) Less aggressive treatment and worse overall survival in cancer patients with diabetes: a large population based analysis. Int J Cancer 120(9):1986–1992. https://doi.org/10.1002/ijc.22532 CrossRefPubMed

21.

Gross CP, Guo Z, McAvay GJ, Allore HG, Young M, Tinetti ME (2006) Multimorbidity and survival in older persons with colorectal cancer. J Am Geriatr Soc 54(12):1898–1904. https://doi.org/10.1111/j.1532-5415.2006.00973.x CrossRefPubMed

22.

Meyerhardt JA, Catalano PJ, Haller DG, Mayer RJ, Macdonald JS, Benson AB III, Fuchs CS (2003) Impact of diabetes mellitus on outcomes in patients with colon cancer. J Clin Oncol 21(3):433–440. https://doi.org/10.1200/JCO.2003.07.125 CrossRefPubMed

23.

Jullumstr E, Kollind M, Lydersen S, Edna T (2009) Diabetes mellitus and outcomes of colorectal cancer. Acta Oncol 48(3):361–367. https://doi.org/10.1080/02841860802637765 CrossRef

24.

Huang Y, Lin J, Chen W, Lin T, Yang S, Jiang J et al (2011) Diabetes mellitus negatively impacts survival of patients with colon cancer, particularly in stage II disease. J Cancer Res Clin Oncol 137(2):211–220. https://doi.org/10.1007/s00432-010-0879-7 CrossRefPubMed

25.

Bella F, Minicozzi P, Giacomin A, Crocetti E, Federico M, De Leon MP et al (2013) Impact of diabetes on overall and cancer-specific mortality in colorectal cancer patients. J Cancer Res Clin Oncol 139(8):1303–1310. https://doi.org/10.1007/s00432-013-1439-8 CrossRefPubMed

26.

Polednak AP (2006) Comorbid diabetes mellitus and risk of death after diagnosis of colorectal cancer: a population-based study. Cancer Detect Prev 30(5):466–472. https://doi.org/10.1016/j.cdp.2006.07.003 CrossRefPubMed

27.

Dehal AN, Newton CC, Jacobs EJ, Patel AV, Gapstur SM, Campbell PT (2011) Impact of diabetes mellitus and insulin use on survival after colorectal cancer diagnosis: the Cancer Prevention Study-II Nutrition Cohort. J Clin Oncol 30(1):53–59. https://doi.org/10.1200/JCO.2011.38.0303 CrossRefPubMed

28.

Feng J, Zhou X, Mao W (2011) Prognostic analysis of colorectal cancer patients with diabetes mellitus in China–the experience of a single institution. Adv Clin Exp Med 20:473–480

29.

Bao Y, Nimptsch K, Meyerhardt JA, Chan AT, Ng K, Michaud DS, Brand-Miller JC, Willett WC, Giovannucci E, Fuchs CS (2010) Dietary insulin load, dietary insulin index, and colorectal cancer. Cancer Epidemiol Biomarkers Prev 19(12):3020–3026. https://doi.org/10.1158/1055-9965.EPI-10-0833 CrossRefPubMedPubMedCentral

30.

Barone BB, Yeh H, Snyder CF, Peairs KS, Stein KB, Derr RL, Wolff AC, Brancati FL (2008) Long-term all-cause mortality in cancer patients with preexisting diabetes mellitus: a systematic review and meta-analysis. JAMA 300(23):2754–2764. https://doi.org/10.1001/jama.2008.824 CrossRefPubMedPubMedCentral

31.

Stein KB, Snyder CF, Barone BB, Yeh H, Peairs KS, Derr RL et al (2010) Colorectal cancer outcomes, recurrence, and complications in persons with and without diabetes mellitus: a systematic review and meta-analysis. Dig Dis Sci 55(7):1839–1851. https://doi.org/10.1007/s10620-009-0944-8 CrossRefPubMedPubMedCentral

32.

33.

Mills KT, Bellows CF, Hoffman AE, Kelly TN, Gagliardi G (2013) Diabetes and colorectal cancer prognosis: a meta-analysis. Dis Colon Rectum 56(11):1304–1319. https://doi.org/10.1097/DCR.0b013e3182a479f9 CrossRefPubMedPubMedCentral

34.

Tsai C, Giovannucci EL (2012) Hyperinsulinemia, insulin resistance, vitamin d, and colorectal cancer among whites and African Americans. Dig Dis Sci 57(10):2497–2503. https://doi.org/10.1007/s10620-012-2198-0 CrossRefPubMed

35.

Giovannucci E (2007) Metabolic syndrome, hyperinsulinemia, and colon cancer: a review. Am J Clin Nutr 86(3):842S–842S. https://doi.org/10.1093/ajcn/86.3.836S CrossRef

36.

Luo R, Giordano SH, Freeman JL, Zhang D, Goodwin JS (2006) Referral to medical oncology: a crucial step in the treatment of older patients with stage III colon cancer. Oncologist 11(9):1025–1033. https://doi.org/10.1634/theoncologist.11-9-102539 CrossRefPubMed

37.

Gross CP, McAvay GJ, Guo Z, Tinetti ME (2007) The impact of chronic illnesses on the use and effectiveness of adjuvant chemotherapy for colon cancer. Cancer 109(12):2410–2419 10.1002/cncr.22726CrossRefPubMed

38.

Bradley CJ, Given CW, Dahman B, Fitzgerald TL (2008) Adjuvant chemotherapy after resection in elderly Medicare and Medicaid patients with colon cancer. Arch Intern Med 168(5):521–529. https://doi.org/10.1001/archinternmed.2007.82 CrossRefPubMed

39.

O’Grady MA, Slater E, Sigurdson ER, Meropol NJ, Weinstein A, Lusch CJ, Sein E, Keeley P, Miller B, Engstrom PF, Cohen SJ (2011) Assessing compliance with national comprehensive cancer network guidelines for elderly patients with stage III colon cancer: the Fox Chase Cancer Center Partners’ initiative. Clin Colorectal Cancer 10(2):113–116. https://doi.org/10.1016/j.clcc.2011.03.007 CrossRefPubMedPubMedCentral

40.

Stratton IM, Cull CA, Adler AI, Matthews DR, Neil H, Holman RR (2006) Additive effects of glycaemia and blood pressure exposure on risk of complications in type 2 diabetes: a prospective observational study (UKPDS 75). Diabetologia 49(8):1761–1769. https://doi.org/10.1007/s00125-006-0297-1 CrossRefPubMed

41.

Irizarry L, Li QE, Duncan I, Thurston AL, Fitzner KA, Edwards BJ, McKoy-Bent JM, Tulas KM, McKoy JM (2013) Effects of cancer comorbidity on disease management: making the case for diabetes education (a report from the SOAR program). Popul Health Manag 16(1):53–57. https://doi.org/10.1089/pop.2012.0028 CrossRefPubMedPubMedCentral

42.

Smith M, Towne S, Herrera-Venson A, Cameron K, Horel S, Ory M, Gilchrist C, Schneider E, DiCocco C, Skowronski S (2018) Delivery of fall prevention interventions for at-risk older adults in rural areas: findings from a national dissemination. Int J Environ Res Public Health 15(12):2798. https://doi.org/10.3390/ijerph15122798 CrossRefPubMedCentral

43.

Ory MG, Smith ML, Patton K, Lorig K, Zenker W, Whitelaw N (2013) Self-management at the tipping point: reaching 100,000 Americans with evidence-based programs. J Am Geriatr Soc 61(5):821–823. https://doi.org/10.1111/jgs.12239 CrossRefPubMed

44.

Ory MG, Ahn S, Jiang L, Smith ML, Ritter PL, Whitelaw N, Lorig K (2013) Successes of a national study of the chronic disease self-management program: meeting the triple aim of health care reform. Med Care 51(11):992–998CrossRefPubMed

45.

Ory MG, Ahn S, Jiang L, Lorig K, Ritter P, Laurent DD, Whitelaw N, Smith ML (2013) National study of chronic disease self-management: six-month outcome findings. J Aging Health 25(7):1258–1274. https://doi.org/10.1177/0898264313502531 CrossRefPubMed

46.

Ahn S, Basu R, Smith ML, Jiang L, Lorig K, Whitelaw N, Ory MG (2013) The impact of chronic disease self-management programs: healthcare savings through a community-based intervention. BMC Public Health 13(1):1141. https://doi.org/10.1186/1471-2458-13-1141 CrossRefPubMedPubMedCentral

47.

Mills KT, Bellows CF, Hoffman AE, Kelly TN, Gagliardi G (2013) Diabetes mellitus and colorectal cancer prognosis: a meta-analysis. Dis Colon Rectum 56(11):1304–1319. https://doi.org/10.1097/DCR.0b013e3182a479f9 CrossRefPubMedPubMedCentral

Titel: Role of pre-existing type 2 diabetes in colorectal cancer survival among older Americans: a SEER-Medicare population-based study 2002–2011
verfasst von: Sanae El brahimi
Matthew Lee Smith
Paulo S. Pinheiro
Publikationsdatum: 09.07.2019
Verlag: Springer Berlin Heidelberg
Erschienen in: International Journal of Colorectal Disease / Ausgabe 8/2019
Print ISSN: 0179-1958
Elektronische ISSN: 1432-1262
DOI: https://doi.org/10.1007/s00384-019-03345-8

Neu im Fachgebiet Chirurgie

Wie erfolgreich ist eine Re-Ablation nach Rezidiv?

23.04.2024 Ablationstherapie Nachrichten

Nach der Katheterablation von Vorhofflimmern kommt es bei etwa einem Drittel der Patienten zu Rezidiven, meist binnen eines Jahres. Wie sich spätere Rückfälle auf die Erfolgschancen einer erneuten Ablation auswirken, haben Schweizer Kardiologen erforscht.

Hinter dieser Appendizitis steckte ein Erreger

23.04.2024 Appendizitis Nachrichten

Schmerzen im Unterbauch, aber sonst nicht viel, was auf eine Appendizitis hindeutete: Ein junger Mann hatte Glück, dass trotzdem eine Laparoskopie mit Appendektomie durchgeführt und der Wurmfortsatz histologisch untersucht wurde.

Mehr Schaden als Nutzen durch präoperatives Aussetzen von GLP-1-Agonisten?

23.04.2024 Operationsvorbereitung Nachrichten

Derzeit wird empfohlen, eine Therapie mit GLP-1-Rezeptoragonisten präoperativ zu unterbrechen. Eine neue Studie nährt jedoch Zweifel an der Notwendigkeit der Maßnahme.

Ureterstriktur: Innovative OP-Technik bewährt sich

19.04.2024 EAU 2024 Kongressbericht

Die Ureterstriktur ist eine relativ seltene Komplikation, trotzdem bedarf sie einer differenzierten Versorgung. In komplexen Fällen wird dies durch die roboterassistierte OP-Technik gewährleistet. Erste Resultate ermutigen.

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Aktuelle BDC Leitlinien-Webinare

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare

CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare

CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske

Dr. med. Benjamin Meyknecht

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare

CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric

Springer Medizin

Abstract

Purpose

Methods

Results

Conclusion

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 8/2019

The risk of nodal disease in patients with pathological complete responses after neoadjuvant chemoradiation for rectal cancer: a systematic review, meta-analysis, and meta-regression

Prospective randomized clinical trial of uncomplicated right-sided colonic diverticulitis: antibiotics versus no antibiotics

Ambulatory versus conventional laparoscopic appendectomy: a systematic review and meta-analysis

The prognostic effect of adjuvant chemotherapy in the colon cancer patients with solitary lymph node metastasis

Appendicolith appendicitis is clinically complicated acute appendicitis—is it histopathologically different from uncomplicated acute appendicitis

Synchronous pathologic findings in patients with colorectal cancer and preoperative incomplete colonoscopy

Update Chirurgie